Hasta la próxima

Auto reproducción

PM1183 plus doxorubicin shows interesting activity in small cell lung cancer

2 vistas • 07/14/23
Compartir
Empotrar
administrator
administrator
Suscriptores
0

Visit http://www.ecancer.org for more

Dr Calvo (START Madrid, Madrid, Spain) talks to ecancertv at ASCO 2015 about data from a Phase 1b study of the transcriptional inhibitor PM1183 in combination with doxorubicin in second line therapy in patients with small cell lung cancer (SCLC)

Mostrar más
0 Comentarios sort Ordenar por
Comentarios de Facebook

Hasta la próxima

Auto reproducción